211 related articles for article (PubMed ID: 22198512)
1. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
Yoon SJ; Park S; Park C; Chang W; Cho DK; Ko YG; Choi D; Kwon HM; Jang Y; Chung N
Coron Artery Dis; 2012 Mar; 23(2):85-90. PubMed ID: 22198512
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension.
Dimitriadis K; Tsioufis C; Kasiakogias A; Miliou A; Poulakis M; Kintis K; Bafakis I; Benardis E; Tousoulis D; Stefanadis C
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):382-8. PubMed ID: 22212601
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
Tam LS; Shang Q; Li EK; Wong S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
5. Arterial stiffness and wave reflections in relation to plasma advanced glycation end products in a Chinese population.
Huang QF; Sheng CS; Liu M; Li FH; Li Y; Wang JG
Am J Hypertens; 2013 Jun; 26(6):754-61. PubMed ID: 23449605
[TBL] [Abstract][Full Text] [Related]
6. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products and arterial stiffness in hypertension.
McNulty M; Mahmud A; Feely J
Am J Hypertens; 2007 Mar; 20(3):242-7. PubMed ID: 17324733
[TBL] [Abstract][Full Text] [Related]
8. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
Leonardis D; Basta G; Mallamaci F; Cutrupi S; Pizzini P; Tripepi R; Tripepi G; De Caterina R; Zoccali C
Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
Su XD; Li SS; Tian YQ; Zhang ZY; Zhang GZ; Wang LX
Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
[TBL] [Abstract][Full Text] [Related]
11. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients.
Yokota C; Minematsu K; Tomii Y; Naganuma M; Ito A; Nagasawa H; Yamaguchi T
J Neurol Sci; 2009 Dec; 287(1-2):41-4. PubMed ID: 19801152
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptor for advanced glycation end products and liver stiffness in postoperative biliary atresia.
Honsawek S; Vejchapipat P; Payungporn S; Theamboonlers A; Chongsrisawat V; Poovorawan Y
Clin Biochem; 2013 Feb; 46(3):214-8. PubMed ID: 23195134
[TBL] [Abstract][Full Text] [Related]
13. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.
Geroldi D; Falcone C; Emanuele E; D'Angelo A; Calcagnino M; Buzzi MP; Scioli GA; Fogari R
J Hypertens; 2005 Sep; 23(9):1725-9. PubMed ID: 16093918
[TBL] [Abstract][Full Text] [Related]
16. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.
Pietri P; Vyssoulis G; Vlachopoulos C; Zervoudaki A; Gialernios T; Aznaouridis K; Stefanadis C
J Hypertens; 2006 Nov; 24(11):2231-8. PubMed ID: 17053545
[TBL] [Abstract][Full Text] [Related]
17. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
19. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
